BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ostroumov D, Fekete-Drimusz N, Saborowski M, Kühnel F, Woller N. CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell Mol Life Sci 2018;75:689-713. [PMID: 29032503 DOI: 10.1007/s00018-017-2686-7] [Cited by in Crossref: 135] [Cited by in F6Publishing: 132] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 Ji YS, Park SK, Ryu S. Whole leukemia cell vaccines: Past progress and future directions. Vaccine 2020;38:3811-20. [PMID: 32280046 DOI: 10.1016/j.vaccine.2020.03.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ribeiro Franco PI, Rodrigues AP, de Menezes LB, Pacheco Miguel M. Tumor microenvironment components: Allies of cancer progression. Pathol Res Pract 2020;216:152729. [PMID: 31735322 DOI: 10.1016/j.prp.2019.152729] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
3 Shukla A, Cano-Mejia J, Andricovich J, Burga RA, Sweeney EE, Fernandes R. An Engineered Prussian Blue Nanoparticles-based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH-MYCN Neuroblastoma Model. Adv Nanobiomed Res 2021;1:2100021. [PMID: 34435194 DOI: 10.1002/anbr.202100021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Uppal A, Dehal A, Chang SC, Barrak D, Naeini Y, Jalas JR, Bilchik AJ. The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma. J Gastrointest Surg 2020;24:28-38. [PMID: 31625020 DOI: 10.1007/s11605-019-04403-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gregg RK. Implications of microgravity-induced cell signaling alterations upon cancer cell growth, invasiveness, metastatic potential, and control by host immunity. Int Rev Cell Mol Biol 2021;361:107-64. [PMID: 34074492 DOI: 10.1016/bs.ircmb.2021.01.004] [Reference Citation Analysis]
6 Guo Y, Yang J, Ren K, Tian X, Gao H, Tian X, Zhang X, Kan Q. The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma. Front Immunol 2022;13:861525. [PMID: 35355983 DOI: 10.3389/fimmu.2022.861525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 2020;17:807-21. [PMID: 32612154 DOI: 10.1038/s41423-020-0488-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 76] [Article Influence: 33.0] [Reference Citation Analysis]
8 Zhong B, Zheng J, Wen H, Liao X, Chen X, Rao Y, Yuan P. NEDD4L suppresses PD-L1 expression and enhances anti-tumor immune response in A549 cells. Genes Genomics 2022. [PMID: 35353342 DOI: 10.1007/s13258-022-01238-9] [Reference Citation Analysis]
9 Baxi V, Edwards R, Montalto M, Saha S. Digital pathology and artificial intelligence in translational medicine and clinical practice. Mod Pathol 2021. [PMID: 34611303 DOI: 10.1038/s41379-021-00919-2] [Reference Citation Analysis]
10 Caruntu A, Moraru L, Lupu M, Vasilescu F, Dumitrescu M, Cioplea M, Popp C, Dragusin A, Caruntu C, Zurac S. Prognostic Potential of Tumor-Infiltrating Immune Cells in Resectable Oral Squamous Cell Carcinoma. Cancers (Basel) 2021;13:2268. [PMID: 34066837 DOI: 10.3390/cancers13092268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kim HK, Jeong MG, Hwang ES. Post-Translational Modifications in Transcription Factors that Determine T Helper Cell Differentiation. Mol Cells 2021;44:318-27. [PMID: 33972470 DOI: 10.14348/molcells.2021.0057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Roberto Raúl SG, Damaris IA, Ángel de Jesús JC, Leticia MF. Cry1Ac Protoxin Confers Antitumor Adjuvant Effect in a Triple-Negative Breast Cancer Mouse Model by Improving Tumor Immunity. Breast Cancer (Auckl) 2022;16:11782234211065154. [PMID: 35002244 DOI: 10.1177/11782234211065154] [Reference Citation Analysis]
13 Kang L, Miao MS, Song YG, Fang XY, Zhang J, Zhang YN, Miao JX. Total flavonoids of Taraxacum mongolicum inhibit non-small cell lung cancer by regulating immune function. J Ethnopharmacol 2021;281:114514. [PMID: 34384846 DOI: 10.1016/j.jep.2021.114514] [Reference Citation Analysis]
14 Peng J, Hao Y, Rao B, Cao Y. Prognostic impact of the pre-treatment controlling nutritional status score in patients with non-small cell lung cancer: A meta-analysis. Medicine (Baltimore) 2021;100:e26488. [PMID: 34190175 DOI: 10.1097/MD.0000000000026488] [Reference Citation Analysis]
15 Banstola A, Poudel K, Kim JO, Jeong JH, Yook S. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death. J Control Release 2021;337:505-20. [PMID: 34314800 DOI: 10.1016/j.jconrel.2021.07.038] [Reference Citation Analysis]
16 Márquez-Garbán DC, Deng G, Comin-Anduix B, Garcia AJ, Xing Y, Chen HW, Cheung-Lau G, Hamilton N, Jung ME, Pietras RJ. Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy. J Steroid Biochem Mol Biol 2019;193:105415. [PMID: 31226312 DOI: 10.1016/j.jsbmb.2019.105415] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
17 Dong X, Cheng R, Zhu S, Liu H, Zhou R, Zhang C, Chen K, Mei L, Wang C, Su C, Liu X, Gu Z, Zhao Y. A Heterojunction Structured WO2.9-WSe2 Nanoradiosensitizer Increases Local Tumor Ablation and Checkpoint Blockade Immunotherapy upon Low Radiation Dose. ACS Nano 2020;14:5400-16. [PMID: 32324373 DOI: 10.1021/acsnano.9b08962] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 27.0] [Reference Citation Analysis]
18 Elsaed WM. Amygdalin (Vitamin B17) pretreatment attenuates experimentally induced acute autoimmune hepatitis through reduction of CD4+ cell infiltration. Annals of Anatomy - Anatomischer Anzeiger 2019;224:124-32. [DOI: 10.1016/j.aanat.2019.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
19 Topchyan P, Xin G, Chen Y, Zheng S, Burns R, Shen J, Kasmani MY, Kudek M, Yang N, Cui W. Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response. Cancers (Basel) 2021;13:1263. [PMID: 33809259 DOI: 10.3390/cancers13061263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gao Z, Wu D, Zheng W, Zhu T, Sun T, Yuan L, Fei F, Fu P. Prognostic value of immune-related lncRNA pairs in patients with bladder cancer. World J Surg Oncol 2021;19:304. [PMID: 34663340 DOI: 10.1186/s12957-021-02419-8] [Reference Citation Analysis]
21 Woller N, Engelskircher SA, Wirth T, Wedemeyer H. Prospects and Challenges for T Cell-Based Therapies of HCC. Cells 2021;10:1651. [PMID: 34209393 DOI: 10.3390/cells10071651] [Reference Citation Analysis]
22 Zou XL, Li XB, Ke H, Zhang GY, Tang Q, Yuan J, Zhou CJ, Zhang JL, Zhang R, Chen WY. Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer. Front Immunol 2021;12:689076. [PMID: 34992591 DOI: 10.3389/fimmu.2021.689076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Wei B, Feng H, Wu H. Reduced CCR2 Can Improve the Prognosis of Sarcoma by Remodeling the Tumor Microenvironment. IJGM 2022;Volume 15:3043-53. [DOI: 10.2147/ijgm.s349295] [Reference Citation Analysis]
24 Hu H, Yang M, Dong W, Yin B, Ding J, Huang B, Zheng Q, Li F, Han L. A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer. Front Oncol 2022;12:873725. [DOI: 10.3389/fonc.2022.873725] [Reference Citation Analysis]
25 Saleh R, Sasidharan Nair V, Toor SM, Taha RZ, Murshed K, Al-Dhaheri M, Khawar M, Petkar MA, Abu Nada M, Al-Ejeh F, Elkord E. Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis. J Immunother Cancer 2020;8:e001294. [PMID: 32948653 DOI: 10.1136/jitc-2020-001294] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
26 Cheng R, Xu Z, Luo M, Wang P, Cao H, Jin X, Zhou W, Xiao L, Jiang Q. Identification of alternative splicing-derived cancer neoantigens for mRNA vaccine development. Briefings in Bioinformatics. [DOI: 10.1093/bib/bbab553] [Reference Citation Analysis]
27 Zheng B, Wang J, Cai W, Lao I, Shi Y, Luo X, Yan W. Changes in the tumor immune microenvironment in resected recurrent soft tissue sarcomas. Ann Transl Med 2019;7:387. [PMID: 31555701 DOI: 10.21037/atm.2019.07.43] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 Galon J, Bruni D. The Role of the Immune Infiltrate in Distinct Cancer Types and Its Clinical Implications : Lymphocytic Infiltration in Colorectal Cancer. Cancer Treat Res 2020;180:197-211. [PMID: 32215871 DOI: 10.1007/978-3-030-38862-1_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wu Z, Lu Z, Li L, Ma M, Long F, Wu R, Huang L, Chou J, Yang K, Zhang Y, Li X, Hu G, Zhang Y, Lin C. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Front Immunol 2021;12:783362. [PMID: 35154072 DOI: 10.3389/fimmu.2021.783362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
30 Caruntu A, Moraru L, Surcel M, Munteanu A, Tanase C, Constantin C, Zurac S, Caruntu C, Neagu M. Assessment of Immune Cell Populations in Tumor Tissue and Peripheral Blood Samples from Head and Neck Squamous Cell Carcinoma Patients. Anal Cell Pathol (Amst) 2021;2021:2328218. [PMID: 34692375 DOI: 10.1155/2021/2328218] [Reference Citation Analysis]
31 Ietto G. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis). Med Hypotheses 2020;141:109779. [PMID: 32387756 DOI: 10.1016/j.mehy.2020.109779] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
32 Lou Y, Wang J, Peng P, Wang S, Liu P, Xu LX. Downregulated TNF-α Levels after Cryo-Thermal Therapy Drive Tregs Fragility to Promote Long-Term Antitumor Immunity. Int J Mol Sci 2021;22:9951. [PMID: 34576115 DOI: 10.3390/ijms22189951] [Reference Citation Analysis]
33 Lin Z, Pang K, Li H, Zhang X, Wan J, Zheng T, Liu T, Peng W. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma. Front Cell Dev Biol 2021;9:709241. [PMID: 34631703 DOI: 10.3389/fcell.2021.709241] [Reference Citation Analysis]
34 Saleh R, Sasidharan Nair V, Murshed K, Abu Nada M, Elkord E, Shaheen R. Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer. Cancer Immunol Immunother 2021;70:2625-38. [PMID: 33582867 DOI: 10.1007/s00262-021-02879-7] [Reference Citation Analysis]
35 Fan M, Jiang M. Core-shell nanotherapeutics with leukocyte membrane camouflage for biomedical applications. Journal of Drug Targeting 2020;28:873-81. [DOI: 10.1080/1061186x.2020.1757102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
36 Wang J, Liu Y, Ni W, Wu X, Zhou J, Zhang Z, Zhou H, Zhang N, Jiang M, Sang Q, Yuan H, Tai G. TRAF6-overexpressing dendritic cells loaded with MUC1 peptide enhance anti-tumor activity in B16-MUC1 melanoma-bearing mice. International Immunopharmacology 2022;107:108667. [DOI: 10.1016/j.intimp.2022.108667] [Reference Citation Analysis]
37 Wan Mohd Zawawi WFA, Hibma MH, Salim MI, Jemon K. Hyperthermia by near infrared radiation induced immune cells activation and infiltration in breast tumor. Sci Rep 2021;11:10278. [PMID: 33986437 DOI: 10.1038/s41598-021-89740-0] [Reference Citation Analysis]
38 Xie S, Shan XF, Yau V, Zhang JY, Zhang XY, Yan YP, Cai ZG. Hyperion imaging system reveals heterogeneous tumor microenvironment of oral squamous cell carcinoma patients at T1N0M0 stage. Ann Transl Med 2020;8:1513. [PMID: 33313258 DOI: 10.21037/atm-20-7194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
39 Yun S, Lee S, Lee HY, Oh HJ, Kwak Y, Lee HS. Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases. Int J Mol Sci 2021;22:7042. [PMID: 34208855 DOI: 10.3390/ijms22137042] [Reference Citation Analysis]
40 Mishra S, Charan M, Shukla RK, Agarwal P, Misri S, Verma AK, Ahirwar DK, Siddiqui J, Kaul K, Sahu N, Vyas K, Garg AA, Khan A, Miles WO, Song JW, Bhutani N, Ganju RK. cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment. J Exp Clin Cancer Res 2022;41:54. [PMID: 35135586 DOI: 10.1186/s13046-021-02221-0] [Reference Citation Analysis]
41 Mendoza-Rodríguez MG, Sánchez-Barrera CÁ, Callejas BE, García-Castillo V, Beristain-Terrazas DL, Delgado-Buenrostro NL, Chirino YI, León-Cabrera SA, Rodríguez-Sosa M, Gutierrez-Cirlos EB, Pérez-Plasencia C, Vaca-Paniagua F, Meraz-Ríos MA, Terrazas LI. Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. Int J Mol Sci 2020;21:E2130. [PMID: 32244885 DOI: 10.3390/ijms21062130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
42 Wang Y, Zhang Q, Chen Y, Liang CL, Liu H, Qiu F, Dai Z. Antitumor effects of immunity-enhancing traditional Chinese medicine. Biomed Pharmacother. 2020;121:109570. [PMID: 31710893 DOI: 10.1016/j.biopha.2019.109570] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
43 Kang J, li N, Wang F, Wei Y, Zeng Y, Luo Q, Sun X, Xu H, Peng J, Zhou F. Exploration of Reduced Mitochondrial Content–Associated Gene Signature and Immunocyte Infiltration in Colon Adenocarcinoma by an Integrated Bioinformatic Analysis. Front Genet 2022;13:832331. [DOI: 10.3389/fgene.2022.832331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Hadjigol S, Shah BA, O’brien-simpson NM. The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes. Front Immunol 2022;13:894021. [DOI: 10.3389/fimmu.2022.894021] [Reference Citation Analysis]
45 Liu Y, Zhang T, Zhang L, Zhao C, Zhang Z, Wang Z, Gu M, Li W, Li B. Combined application of bevacizumab and PD-1 blockade displays durable treatment effects by increasing the infiltration and cytotoxic function of CD8+ T cells in lung cancer. Immunotherapy 2022. [PMID: 35574588 DOI: 10.2217/imt-2021-0196] [Reference Citation Analysis]
46 Shi F, Pang XX, Li GJ, Chen ZH, Dong MY, Wang JL. Genetic association study of intron variants in the forkhead box protein P3 gene in Chinese patients diagnosed with cervical cancer. J Cell Mol Med 2022. [PMID: 35322929 DOI: 10.1111/jcmm.17276] [Reference Citation Analysis]
47 Caruntu A, Scheau C, Tampa M, Georgescu SR, Caruntu C, Tanase C. Complex Interaction Among Immune, Inflammatory, and Carcinogenic Mechanisms in the Head and Neck Squamous Cell Carcinoma. Adv Exp Med Biol 2021. [PMID: 33650087 DOI: 10.1007/5584_2021_626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
48 Slovak RJ, Park HJ, Kamp WM, Ludwig JM, Kang I, Kim HS. Co-inhibitor expression on tumor infiltrating and splenic lymphocytes after dual checkpoint inhibition in a microsatellite stable model of colorectal cancer. Sci Rep 2021;11:6956. [PMID: 33772035 DOI: 10.1038/s41598-021-85810-5] [Reference Citation Analysis]
49 De Vito A, Orecchia P, Balza E, Reverberi D, Scaldaferri D, Taramelli R, Noonan DM, Acquati F, Mortara L. Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection. Cancers (Basel) 2020;12:E717. [PMID: 32197460 DOI: 10.3390/cancers12030717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
50 Supabphol S, Li L, Goedegebuure SP, Gillanders WE. Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy. Expert Opin Investig Drugs 2021;30:529-41. [PMID: 33641576 DOI: 10.1080/13543784.2021.1896702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Peng P, Lou Y, Wang J, Wang S, Liu P, Xu LX. Th1-Dominant CD4+ T Cells Orchestrate Endogenous Systematic Antitumor Immune Memory After Cryo-Thermal Therapy. Front Immunol 2022;13:944115. [DOI: 10.3389/fimmu.2022.944115] [Reference Citation Analysis]
52 Shou Y, Yang L, Yang Y, Zhu X, Li F, Xu J. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma. Mol Omics 2021;17:307-16. [PMID: 33624645 DOI: 10.1039/d0mo00159g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Song WM, Agrawal P, Von Itter R, Fontanals-Cirera B, Wang M, Zhou X, Mahal LK, Hernando E, Zhang B. Network models of primary melanoma microenvironments identify key melanoma regulators underlying prognosis. Nat Commun 2021;12:1214. [PMID: 33619278 DOI: 10.1038/s41467-021-21457-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Kurozumi S, Kaira K, Matsumoto H, Hirakata T, Yokobori T, Inoue K, Horiguchi J, Katayama A, Koshi H, Shimizu A, Oyama T, Sloan EK, Kurosumi M, Fujii T, Shirabe K. β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer. Breast Cancer Res Treat 2019;177:603-10. [PMID: 31290053 DOI: 10.1007/s10549-019-05341-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
55 Antohe I, Dǎscǎlescu A, Dǎnǎilǎ C, Titieanu A, Zlei M, Ivanov I, Sireteanu A, Pavel M, Cianga P. B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles. Front Oncol 2020;10:264. [PMID: 32231996 DOI: 10.3389/fonc.2020.00264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
56 Frigerio S, Lartey DA, D'Haens GR, Grootjans J. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. Int J Mol Sci 2021;22:12739. [PMID: 34884543 DOI: 10.3390/ijms222312739] [Reference Citation Analysis]
57 Kimm MA, Klenk C, Alunni-Fabbroni M, Kästle S, Stechele M, Ricke J, Eisenblätter M, Wildgruber M. Tumor-Associated Macrophages-Implications for Molecular Oncology and Imaging. Biomedicines 2021;9:374. [PMID: 33918295 DOI: 10.3390/biomedicines9040374] [Reference Citation Analysis]
58 Ozaniak A, Vachtenheim J Jr, Lischke R, Bartunkova J, Strizova Z. Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective? Biomedicines 2021;9:935. [PMID: 34440139 DOI: 10.3390/biomedicines9080935] [Reference Citation Analysis]
59 Hoffmann MM, Slansky JE. T-cell receptor affinity in the age of cancer immunotherapy. Mol Carcinog 2020;59:862-70. [PMID: 32386086 DOI: 10.1002/mc.23212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
60 Ray AL, Nofchissey RA, Khan MA, Reidy MA, Lerner MR, Wu X, Guo S, Hill SL, Weygant N, Adams SF, Castillo EF, Berry WL, Stout MB, Morris KT. The role of sex in the innate and adaptive immune environment of metastatic colorectal cancer. Br J Cancer 2020;123:624-32. [PMID: 32451467 DOI: 10.1038/s41416-020-0913-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Ramesh P, Shivde R, Jaishankar D, Saleiro D, Le Poole IC. A Palette of Cytokines to Measure Anti-Tumor Efficacy of T Cell-Based Therapeutics. Cancers (Basel) 2021;13:821. [PMID: 33669271 DOI: 10.3390/cancers13040821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Fedele V, Melisi D. Permissive State of EMT: The Role of Immune Cell Compartment. Front Oncol 2020;10:587. [PMID: 32391271 DOI: 10.3389/fonc.2020.00587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
63 Friedman A, Siewe N. Overcoming Drug Resistance to BRAF Inhibitor. Bull Math Biol 2020;82:8. [PMID: 31933021 DOI: 10.1007/s11538-019-00691-0] [Reference Citation Analysis]
64 Qu X, Shi Z, Guo J, Guo C, Qiu J, Hua K. Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer. Cancer Med 2021;10:6881-96. [PMID: 34498424 DOI: 10.1002/cam4.4054] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Shi C, Han W, Zhang M, Zang R, Du K, Li L, Xu X, Li C, Wang S, Qiu P, Guan H, Yang J, Xiao S, Wang X. Sulfated polymannuroguluronate TGC161 ameliorates leukopenia by inhibiting CD4+ T cell apoptosis. Carbohydr Polym 2020;247:116728. [PMID: 32829850 DOI: 10.1016/j.carbpol.2020.116728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Filipić B, Stojić-vukanić Z. Active immunotherapy of cancer: An overview of therapeutic vaccines. Arhiv za farmaciju 2019;69:490-506. [DOI: 10.5937/arhfarm1906490f] [Reference Citation Analysis]
67 Ren Y, Cherukuri Y, Wickland DP, Sarangi V, Tian S, Carter JM, Mansfield AS, Block MS, Sherman ME, Knutson KL, Lin Y, Asmann YW. HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer. Oncoimmunology 2020;9:1744947. [PMID: 32523802 DOI: 10.1080/2162402X.2020.1744947] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
68 Wu Z, Zhang C, Najafi M. Targeting of the tumor immune microenvironment by metformin. J Cell Commun Signal 2021. [PMID: 34611852 DOI: 10.1007/s12079-021-00648-w] [Reference Citation Analysis]
69 He X, Jiang XH, Yie KY, Chen J, Zhang JB, Yie SM. An autoantibody against a 48-Kd fragment of human DNA-topoiomerase I in breast cancer: Implication for diagnosis and prognosis, and antibody-dependent cellular cytotoxicity in vitro. Cell Immunol 2020;347:104007. [PMID: 31732123 DOI: 10.1016/j.cellimm.2019.104007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
70 Maskey N, Thapa N, Maharjan M, Shrestha G, Maharjan N, Cai H, Liu S. Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu. Cancer Manag Res 2019;11:7647-55. [PMID: 31616181 DOI: 10.2147/CMAR.S217264] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
71 Geskovski N, Sazdovska SD, Goracinova K. Macroalgal Polysaccharides in Biomimetic Nanodelivery Systems. Curr Pharm Des 2019;25:1265-89. [PMID: 31020934 DOI: 10.2174/1381612825666190423155116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
72 Hofer T, Rossi M, Carboni S, Di Berardino Besson W, von Laer D, Wollmann G, Derouazi M, Santiago-Raber ML. Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect. Cancers (Basel) 2021;13:6107. [PMID: 34885215 DOI: 10.3390/cancers13236107] [Reference Citation Analysis]
73 Srinivasan S, Yee NA, Wu K, Zakharian M, Mahmoodi A, Royzen M, Oneto JMM. SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected & Non-injected Lesions. Adv Ther (Weinh) 2021;4:2000243. [PMID: 33869738 DOI: 10.1002/adtp.202000243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
74 Miracco C, Toti P, Gelmi MC, Aversa S, Baldino G, Galluzzi P, De Francesco S, Petrelli F, Sorrentino E, Belmonte G, Galimberti D, Bracco S, Hadjistilianou T. Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1- Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After Chemotherapy. Invest Ophthalmol Vis Sci 2021;62:6. [PMID: 33538768 DOI: 10.1167/iovs.62.2.6] [Reference Citation Analysis]
75 Choudhury SM, Ma X, Dang W, Li Y, Zheng H. Recent Development of Ruminant Vaccine Against Viral Diseases. Front Vet Sci 2021;8:697194. [PMID: 34805327 DOI: 10.3389/fvets.2021.697194] [Reference Citation Analysis]
76 Wang D, Hu X, Xiao L, Long G, Yao L, Wang Z, Zhou L. Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC. J Gastrointest Surg 2021;25:421-7. [PMID: 32026332 DOI: 10.1007/s11605-019-04492-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
77 Power R, Lowery MA, Reynolds JV, Dunne MR. The Cancer-Immune Set Point in Oesophageal Cancer. Front Oncol. 2020;10:891. [PMID: 32582553 DOI: 10.3389/fonc.2020.00891] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
78 Shemesh CS, Hsu JC, Hosseini I, Shen BQ, Rotte A, Twomey P, Girish S, Wu B. Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities. Mol Ther 2021;29:555-70. [PMID: 33038322 DOI: 10.1016/j.ymthe.2020.09.038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
79 Newport EL, Pedrosa AR, Njegic A, Hodivala-Dilke KM, Muñoz-Félix JM. Improved Immunotherapy Efficacy by Vascular Modulation. Cancers (Basel) 2021;13:5207. [PMID: 34680355 DOI: 10.3390/cancers13205207] [Reference Citation Analysis]
80 Cardoso Alves L, Corazza N, Micheau O, Krebs P. The multifaceted role of TRAIL signaling in cancer and immunity. FEBS J 2020. [PMID: 33215853 DOI: 10.1111/febs.15637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
81 Cavallari C, Camussi G, Brizzi MF. Extracellular Vesicles in the Tumour Microenvironment: Eclectic Supervisors. Int J Mol Sci 2020;21:E6768. [PMID: 32942702 DOI: 10.3390/ijms21186768] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
82 Okoye I, Xu L, Motamedi M, Parashar P, Walker JW, Elahi S. Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors. J Immunother Cancer 2020;8:e001849. [PMID: 33310773 DOI: 10.1136/jitc-2020-001849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
83 Zhu M, Li X, Cheng X, Yi X, Ye F, Li X, Hu Z, Zhang L, Nie J, Li X. Association of the tissue infiltrated and peripheral blood immune cell subsets with response to radiotherapy for rectal cancer. BMC Med Genomics 2022;15:107. [PMID: 35534879 DOI: 10.1186/s12920-022-01252-6] [Reference Citation Analysis]
84 Huff WX, Kwon JH, Henriquez M, Fetcko K, Dey M. The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology. Int J Mol Sci 2019;20:E2810. [PMID: 31181772 DOI: 10.3390/ijms20112810] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
85 Uche IK, Fowlkes N, Vu L, Watanabe T, Carossino M, Nabi R, Del Piero F, Rudd JS, Kousoulas KG, Rider PJF. Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model. J Virol 2021;95:e01359-20. [PMID: 33177208 DOI: 10.1128/JVI.01359-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
86 Li XY, Yao S, He YT, Ke SQ, Ma YF, Lu P, Nie SF, Wei SZ, Liang XJ, Liu L. Inflammation-Immunity-Nutrition Score: A Novel Prognostic Score for Patients with Resectable Colorectal Cancer. J Inflamm Res 2021;14:4577-88. [PMID: 34531673 DOI: 10.2147/JIR.S322260] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Peng Y, Yang J, Guo D, Zheng C, Sun H, Zhang Q, Zou S, Zhang Y, Luo K, Candiotti KA. Sufentanil postoperative analgesia reduce the increase of T helper 17 (Th17) cells and FoxP3+ regulatory T (Treg) cells in rat hepatocellular carcinoma surgical model: A randomised animal study. BMC Anesthesiol 2020;20:212. [PMID: 32847505 DOI: 10.1186/s12871-020-01129-0] [Reference Citation Analysis]
88 Zhang J, Wang T. Immune cell landscape and immunotherapy of medulloblastoma. Pediatr Investig 2021;5:299-309. [PMID: 34938973 DOI: 10.1002/ped4.12261] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Persano S, Das P, Pellegrino T. Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity. Cancers (Basel) 2021;13:2735. [PMID: 34073106 DOI: 10.3390/cancers13112735] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Hou Z, Liang X, Wang X, Zhou Z, Shi G. Myeloid-derived suppressor cells infiltration in non-small-cell lung cancer tumor and MAGE-A4 and NY-ESO-1 expression. Oncol Lett 2020;19:3982-92. [PMID: 32382343 DOI: 10.3892/ol.2020.11497] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Rath JA, Bajwa G, Carreres B, Hoyer E, Gruber I, Martínez-Paniagua MA, Yu YR, Nouraee N, Sadeghi F, Wu M, Wang T, Hebeisen M, Rufer N, Varadarajan N, Ho PC, Brenner MK, Gfeller D, Arber C. Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4+ T cells. Sci Adv 2020;6:eaaz7809. [PMID: 32923584 DOI: 10.1126/sciadv.aaz7809] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
92 de Carvalho JTG, Da Silva Baldivia D, de Castro DTH, Dos Santos HF, Dos Santos CM, Oliveira AS, Alfredo TM, Vilharva KN, de Picoli Souza K, Dos Santos EL. The immunoregulatory function of polyphenols: implications in cancer immunity. J Nutr Biochem 2020;85:108428. [PMID: 32679443 DOI: 10.1016/j.jnutbio.2020.108428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
93 Rutz J, Janicova A, Woidacki K, Chun FK, Blaheta RA, Relja B. Curcumin-A Viable Agent for Better Bladder Cancer Treatment. Int J Mol Sci 2020;21:E3761. [PMID: 32466578 DOI: 10.3390/ijms21113761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
94 Hayaza S, Wahyuningsih SPA, Susilo RJK, Husen SA, Winarni D, Doong RA, Darmanto W. Dual role of immunomodulation by crude polysaccharide from okra against carcinogenic liver injury in mice. Heliyon 2021;7:e06183. [PMID: 33659734 DOI: 10.1016/j.heliyon.2021.e06183] [Reference Citation Analysis]
95 Karpiński P, Łaczmański Ł, Sąsiadek MM. Major Histocompatibility Complex Genes as Therapeutic Opportunity for Immune Cold Molecular Cancer Subtypes. J Immunol Res 2020;2020:8758090. [PMID: 33282963 DOI: 10.1155/2020/8758090] [Reference Citation Analysis]
96 Henderson JM, Xiang MSW, Huang JC, Wetzel S, Jiang L, Lai JH, Wu W, Kench JG, Bachovchin WW, Roediger B, McCaughan GW, Zhang HE, Gorrell MD. Dipeptidyl Peptidase Inhibition Enhances CD8 T Cell Recruitment and Activates Intrahepatic Inflammasome in a Murine Model of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5495. [PMID: 34771657 DOI: 10.3390/cancers13215495] [Reference Citation Analysis]
97 Hu SJ, Zhao XK, Song X, Lei LL, Han WL, Xu RH, Wang R, Zhou FY, Wang L, Wang LD. Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma. World J Gastroenterol 2021; 27(4): 321-335 [PMID: 33584065 DOI: 10.3748/wjg.v27.i4.321] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
98 Garland-Kledzik M, Uppal A, Naeini YB, Stern S, Erali R, Scholer AJ, Khader AM, Santamaria-Barria JA, Cummins-Perry K, Zhou Y, Votanopoulos KI, Shen P, Levine EA, Bilchik AJ. Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC). J Gastrointest Surg 2021;25:233-40. [PMID: 33269456 DOI: 10.1007/s11605-020-04886-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Pasquini S, Contri C, Borea PA, Vincenzi F, Varani K. Adenosine and Inflammation: Here, There and Everywhere. Int J Mol Sci 2021;22:7685. [PMID: 34299305 DOI: 10.3390/ijms22147685] [Reference Citation Analysis]
100 Wang J, Li Z, Gao A, Wen Q, Sun Y. The prognostic landscape of tumor-infiltrating immune cells in cervical cancer. Biomed Pharmacother 2019;120:109444. [PMID: 31562978 DOI: 10.1016/j.biopha.2019.109444] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
101 Zhao Z, Yin XN, Wang J, Chen X, Cai ZL, Zhang B. Prognostic significance of hemoglobin, albumin, lymphocyte, platelet in gastrointestinal stromal tumors: A propensity matched retrospective cohort study. World J Gastroenterol 2022; 28(27): 3476-3487 [DOI: 10.3748/wjg.v28.i27.3476] [Reference Citation Analysis]
102 Jan HC, Hu CY, Yang WH, Ou CH. Combination of Platelet-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio as a New Promising Prognostic Factor in Upper Tract Urothelial Carcinoma With Large Tumor Sizes > 3 cm. Clin Genitourin Cancer 2020;18:e484-500. [PMID: 32199741 DOI: 10.1016/j.clgc.2019.12.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Ahn SH, Choi JY, Kim SD, Park SJ, Kim H. Accelerated elimination of human cancer cells by a CD40 agonist antibody combined with a PD-1 antagonist in CD4-depleted mice. Oncol Lett 2019;18:5889-96. [PMID: 31788062 DOI: 10.3892/ol.2019.10991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
104 Maibach F, Sadozai H, Seyed Jafari SM, Hunger RE, Schenk M. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma. Front Immunol 2020;11:2105. [PMID: 33013886 DOI: 10.3389/fimmu.2020.02105] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
105 Seliger B. The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment-Review. Front Immunol 2019;10:2043. [PMID: 31555274 DOI: 10.3389/fimmu.2019.02043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
106 Riva G, Nasillo V, Ottomano AM, Bergonzini G, Paolini A, Forghieri F, Lusenti B, Barozzi P, Lagreca I, Fiorcari S, Martinelli S, Maffei R, Marasca R, Potenza L, Comoli P, Manfredini R, Tagliafico E, Trenti T, Luppi M. Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges. Cancers (Basel) 2021;13:4582. [PMID: 34572809 DOI: 10.3390/cancers13184582] [Reference Citation Analysis]
107 Zhu D, Lu Y, Gui L, Wang W, Hu X, Chen S, Wang Y, Wang Y. Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment. Acta Pharm Sin B 2022;12:2592-608. [PMID: 35646534 DOI: 10.1016/j.apsb.2021.11.006] [Reference Citation Analysis]
108 Sellmer L, Kovács J, Neumann J, Walter J, Kauffmann-Guerrero D, Syunyaeva Z, Fertmann J, Schneider C, Zimmermann J, Behr J, Tufman A. Lymphocytes and sinus histiocytosis in tumor and matched lymph nodes as predictors of survival in non-small-cell lung cancer. Future Oncol 2022. [PMID: 35023359 DOI: 10.2217/fon-2021-0402] [Reference Citation Analysis]
109 Miao KZ, Kim GY, Meara GK, Qin X, Feng H. Tipping the Scales With Zebrafish to Understand Adaptive Tumor Immunity. Front Cell Dev Biol 2021;9:660969. [PMID: 34095125 DOI: 10.3389/fcell.2021.660969] [Reference Citation Analysis]
110 Shao FF, Chen BJ, Wu GQ. The functions of EZH2 in immune cells: Principles for novel immunotherapies. J Leukoc Biol 2021;110:77-87. [PMID: 33040370 DOI: 10.1002/JLB.1RU0520-311R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Zhang Q, Liu YJ, Li JP, Zeng SH, Shen H, Han M, Guo S, Liu SL, Zou X. USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma. J Inflamm Res 2022;15:3065-82. [PMID: 35637872 DOI: 10.2147/JIR.S362619] [Reference Citation Analysis]
112 Mardanpour K, Rahbar M, Mardanpour S, Mardanpour N, Rezaei M. CD8+ T-cell lymphocytes infiltration predict clinical outcomes in Wilms' tumor. Tumour Biol 2020;42:1010428320975976. [PMID: 33283684 DOI: 10.1177/1010428320975976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Ljokjel B, Haave H, Lybak S, Vintermyr OK, Helgeland L, Aarstad HJ. Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma. Cancers (Basel) 2022;14:1508. [PMID: 35326661 DOI: 10.3390/cancers14061508] [Reference Citation Analysis]
114 Ott E, Bilonda L, Dansette D, Deleine C, Duchalais E, Podevin J, Volteau C, Bennouna J, Touchefeu Y, Fourquier P, El Alami Thomas W, Chetritt J, Bezieau S, Denis M, Toquet C, Mosnier JF, Jarry A, Bossard C. The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite status. Oncoimmunology 2019;8:e1562834. [PMID: 30906656 DOI: 10.1080/2162402X.2018.1562834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Niesel K, Schulz M, Anthes J, Alekseeva T, Macas J, Salamero-Boix A, Möckl A, Oberwahrenbrock T, Lolies M, Stein S, Plate KH, Reiss Y, Rödel F, Sevenich L. The immune suppressive microenvironment affects efficacy of radio-immunotherapy in brain metastasis. EMBO Mol Med 2021;13:e13412. [PMID: 33755340 DOI: 10.15252/emmm.202013412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
116 Huang SH, McCann CD, Mota TM, Wang C, Lipkin SM, Jones RB. Have Cells Harboring the HIV Reservoir Been Immunoedited? Front Immunol 2019;10:1842. [PMID: 31447850 DOI: 10.3389/fimmu.2019.01842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
117 Kang Y, Datta P, Shanmughapriya S, Ozbolat IT. 3D Bioprinting of Tumor Models for Cancer Research. ACS Appl Bio Mater 2020;3:5552-73. [DOI: 10.1021/acsabm.0c00791] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 7.5] [Reference Citation Analysis]
118 Zhang W, Tang Y, Guo Y, Kong Y, Shi F, Sheng C, Wang S, Wang Q. Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations. NPJ Precis Oncol 2022;6:46. [PMID: 35739249 DOI: 10.1038/s41698-022-00292-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Li Y, Li Z, Deng K, Liao M, Yuan S, Huang Z. Fibrinogen/Lymphocyte Count Ratio Can Be Used as a New Indicator of Prognosis in Patients with Hepatocellular Carcinoma After Radical Resection. Cancer Manag Res 2020;12:9057-66. [PMID: 33061600 DOI: 10.2147/CMAR.S266653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Abed A, Calapre L, Lo J, Correia S, Bowyer S, Chopra A, Watson M, Khattak MA, Millward M, Gray ES. Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy. J Immunother Cancer 2020;8:e001620. [PMID: 33229510 DOI: 10.1136/jitc-2020-001620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
121 Lee LA, Fang TJ, Li HY, Chuang HH, Kang CJ, Chang KP, Liao CT, Chen TC, Huang CG, Yen TC. Effects of Epstein-Barr Virus Infection on the Risk and Prognosis of Primary Laryngeal Squamous Cell Carcinoma: A Hospital-Based Case-Control Study in Taiwan. Cancers (Basel) 2021;13:1741. [PMID: 33917480 DOI: 10.3390/cancers13071741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Moffett S, Shiao TC, Mousavifar L, Mignani S, Roy R. Aberrant glycosylation patterns on cancer cells: Therapeutic opportunities for glycodendrimers/metallodendrimers oncology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1659. [PMID: 32776710 DOI: 10.1002/wnan.1659] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
123 de Assis LVM, Lacerda JT, Moraes MN, Domínguez-Amorocho OA, Kinker GS, Mendes D, Silva MM, Menck CFM, Câmara NOS, Castrucci AML. Melanopsin (Opn4) is an oncogene in cutaneous melanoma. Commun Biol 2022;5:461. [PMID: 35562405 DOI: 10.1038/s42003-022-03425-6] [Reference Citation Analysis]
124 Bilusic M, Girardi D, Zhou Y, Jung K, Pei J, Slifker M, Chen Q, Meerzaman D, Alpaugh K, Young D, Flieder D, Gray P, Plimack E. Molecular Profiling of Exceptional Responders to Cancer Therapy. Oncologist 2021;26:186-95. [PMID: 33210795 DOI: 10.1002/onco.13600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
125 Abu N, Rus Bakarurraini NAA. The interweaving relationship between extracellular vesicles and T cells in cancer. Cancer Lett 2021:S0304-3835(21)00614-5. [PMID: 34906625 DOI: 10.1016/j.canlet.2021.12.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Salminen A. Feed-forward regulation between cellular senescence and immunosuppression promotes the aging process and age-related diseases. Ageing Res Rev 2021;67:101280. [PMID: 33581314 DOI: 10.1016/j.arr.2021.101280] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
127 Jiang X, Yuan Y, Tang L, Wang J, Liu Q, Zou X, Duan L. Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis. Front Cell Dev Biol 2021;9:765772. [PMID: 34858987 DOI: 10.3389/fcell.2021.765772] [Reference Citation Analysis]
128 DeLucia DC, Lee JK. Development of Cancer Immunotherapies. Cancer Treat Res 2022;183:1-48. [PMID: 35551655 DOI: 10.1007/978-3-030-96376-7_1] [Reference Citation Analysis]
129 Wang Y, Huang H, Yao S, Li G, Xu C, Ye Y, Gui S. A lipid-soluble extract of Pinellia pedatisecta Schott enhances antitumor T cell responses by restoring tumor-associated dendritic cell activation and maturation. J Ethnopharmacol 2019;241:111980. [PMID: 31146000 DOI: 10.1016/j.jep.2019.111980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
130 Settanni CR, Quaranta G, Bibbò S, Gasbarrini A, Cammarota G, Ianiro G. Oral supplementation with lactobacilli to prevent colorectal cancer in preclinical models. Minerva Gastroenterol Dietol 2020;66:48-69. [PMID: 31760735 DOI: 10.23736/S1121-421X.19.02631-X] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
131 Cortellini A, Ricciuti B, Borghaei H, Naqash AR, D'Alessio A, Fulgenzi CAM, Addeo A, Banna GL, Pinato DJ. Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022. [PMID: 35727053 DOI: 10.1002/cncr.34348] [Reference Citation Analysis]
132 Li L, Zhao C, Kong F, Li YC, Wang C, Chen S, Tan HY, Liu Y, Wang D. Calf Thymus Polypeptide Restrains the Growth of Colorectal Tumor via Regulating the Intestinal Microbiota-Mediated Immune Function. Front Pharmacol 2022;13:898906. [PMID: 35662701 DOI: 10.3389/fphar.2022.898906] [Reference Citation Analysis]
133 Ramírez A, García-Quiroz J, Aguilar-Eslava L, Sánchez-Pérez Y, Camacho J. Novel Therapeutic Approaches of Ion Channels and Transporters in Cancer. Rev Physiol Biochem Pharmacol 2020. [PMID: 32715321 DOI: 10.1007/112_2020_28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
134 Oslund RC, Reyes-Robles T, White CH, Tomlinson JH, Crotty KA, Bowman EP, Chang D, Peterson VM, Li L, Frutos S, Vila-Perelló M, Vlerick D, Cromie K, Perlman DH, Ingale S, Hara SDO, Roberts LR, Piizzi G, Hett EC, Hazuda DJ, Fadeyi OO. Detection of cell-cell interactions via photocatalytic cell tagging. Nat Chem Biol 2022. [PMID: 35654846 DOI: 10.1038/s41589-022-01044-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Jiang S, Zhang Y, Zhang X, Lu B, Sun P, Wu Q, Ding X, Huang J. GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer. Front Immunol 2021;12:660397. [PMID: 34421887 DOI: 10.3389/fimmu.2021.660397] [Reference Citation Analysis]
136 Hussein NA, Malla S, Pasternak MA, Terrero D, Brown NG, Ashby CR Jr, Assaraf YG, Chen ZS, Tiwari AK. The role of endolysosomal trafficking in anticancer drug resistance. Drug Resist Updat 2021;57:100769. [PMID: 34217999 DOI: 10.1016/j.drup.2021.100769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Farc O, Cristea V. An overview of the tumor microenvironment, from cells to complex networks (Review). Exp Ther Med 2021;21:96. [PMID: 33363607 DOI: 10.3892/etm.2020.9528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
138 Puronen CE, Ford ES, Uldrick TS. Immunotherapy in People With HIV and Cancer. Front Immunol 2019;10:2060. [PMID: 31555284 DOI: 10.3389/fimmu.2019.02060] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
139 Vigano S, Alatzoglou D, Irving M, Ménétrier-Caux C, Caux C, Romero P, Coukos G. Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function. Front Immunol 2019;10:925. [PMID: 31244820 DOI: 10.3389/fimmu.2019.00925] [Cited by in Crossref: 118] [Cited by in F6Publishing: 113] [Article Influence: 39.3] [Reference Citation Analysis]
140 Chen Z, Dong D, Zhu Y, Pang N, Ding J. The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma. FASEB J 2021;35:e21401. [PMID: 33559190 DOI: 10.1096/fj.202000528RR] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
141 Triaca V, Carito V, Fico E, Rosso P, Fiore M, Ralli M, Lambiase A, Greco A, Tirassa P. Cancer stem cells-driven tumor growth and immune escape: the Janus face of neurotrophins. Aging (Albany NY) 2019;11:11770-92. [PMID: 31812953 DOI: 10.18632/aging.102499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
142 Yao H, Jiang X, Fu H, Yang Y, Jin Q, Zhang W, Cao W, Gao W, Wang S, Zhu Y, Ying J, Tian L, Chen G, Tong Z, Qi J, Zhou S. Exploration of the Immune-Related Long Noncoding RNA Prognostic Signature and Inflammatory Microenvironment for Cervical Cancer. Front Pharmacol 2022;13:870221. [PMID: 35662687 DOI: 10.3389/fphar.2022.870221] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Wątek M, Piktel E, Wollny T, Durnaś B, Fiedoruk K, Lech-Marańda E, Bucki R. Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development. Int J Mol Sci 2019;20:E843. [PMID: 30781349 DOI: 10.3390/ijms20040843] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
144 Alvarado-Cruz I, Meas R, Paluri SLA, Carufe KEW, Khan M, Sweasy JB. The double-edged sword of cancer mutations: exploiting neoepitopes for the fight against cancer. Mutagenesis 2020;35:69-78. [PMID: 31880305 DOI: 10.1093/mutage/gez049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Ali DA, El-Guindy DM, Elrashidy MA, Sabry NM, Kabel AM, Gaber RA, Ibrahim RR, Samy SM, Shalaby MM, Salama SA, Abdelhai D. The Prognostic Significance of MACC1 Expression in Breast Cancer and Its Relationship to Immune Cells in the Tumor Microenvironment and Patient Survival. Medicina (Kaunas) 2021;57:934. [PMID: 34577857 DOI: 10.3390/medicina57090934] [Reference Citation Analysis]
146 Zhang LY, Zhang JG, Yang X, Cai MH, Zhang CW, Hu ZM. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery. Curr Top Med Chem 2020;20:2789-800. [PMID: 33076809 DOI: 10.2174/1568026620666201019111524] [Reference Citation Analysis]
147 Junk D, Krämer S, Broschewitz J, Laura H, Massa C, Moulla Y, Hoang NA, Monecke A, Eichfeld U, Bechmann I, Lordick F, Seliger B, Kallendrusch S. Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition. Cell Death Discov 2021;7:264. [PMID: 34564709 DOI: 10.1038/s41420-021-00651-5] [Reference Citation Analysis]
148 Balta E, Wabnitz GH, Samstag Y. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors. Int J Mol Sci 2021;22:5736. [PMID: 34072260 DOI: 10.3390/ijms22115736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
149 Aló PL, Cicciarelli M, De Felice F, Quintiliani C, Corsi A, Polimeni A. Immunohistochemical Differences in Squamous Precancerous and Cancerous Lesions of the Oral Cavity and the Larynx: Preliminary Data. Applied Sciences 2021;11:2048. [DOI: 10.3390/app11052048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
150 Chen M, Brackett CM, Burdelya LG, Punnanitinont A, Patnaik SK, Matsuzaki J, Odunsi AO, Gudkov AV, Singh AK, Repasky EA, Gurova KV. Stimulation of an anti-tumor immune response with "chromatin-damaging" therapy. Cancer Immunol Immunother 2021;70:2073-86. [PMID: 33439292 DOI: 10.1007/s00262-020-02846-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Zhang WJ. Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy. Purinergic Signal 2021;17:151-62. [PMID: 33420658 DOI: 10.1007/s11302-020-09761-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Rakina M, Kazakova A, Villert A, Kolomiets L, Larionova I. Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components. Int J Mol Sci 2022;23:6215. [PMID: 35682890 DOI: 10.3390/ijms23116215] [Reference Citation Analysis]
153 Lu Y, Zhang Q, Zhang L. CD4+ Memory Stem T Cell in Peripheral Blood: A Promising Immune Index for Early Screening and Auxiliary Diagnosis of Colorectal Cancer. Front Oncol 2021;11:701738. [PMID: 34327142 DOI: 10.3389/fonc.2021.701738] [Reference Citation Analysis]
154 Fasano R, Shadbad MA, Brunetti O, Argentiero A, Calabrese A, Nardulli P, Calbi R, Baradaran B, Silvestris N. Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy. Life (Basel) 2021;11:1355. [PMID: 34947886 DOI: 10.3390/life11121355] [Reference Citation Analysis]
155 Caruntu A, Moraru L, Lupu M, Ciubotaru DA, Dumitrescu M, Eftimie L, Hertzog R, Zurac S, Caruntu C, Voinea OC. Assessment of Histological Features in Squamous Cell Carcinoma Involving Head and Neck Skin and Mucosa. J Clin Med 2021;10:2343. [PMID: 34071843 DOI: 10.3390/jcm10112343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
156 Hu J, Wu X, Huang P, Teng F, Wang Y, Xue F. The Proportion and Prognostic Significance of T-Regulatory Cells in Patients with Gynecological Cancers: A Systematic Review and Meta-Analysis. J Cancer 2020;11:3340-8. [PMID: 32231740 DOI: 10.7150/jca.42472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
157 Li X, Wang X, Ito A. An MRI-visible immunoadjuvant based on hollow Gd2O3 nanospheres for cancer immunotherapy. Chem Commun (Camb) 2020;56:8186-9. [PMID: 32618297 DOI: 10.1039/d0cc03568h] [Reference Citation Analysis]
158 Amarillo D, Brugnini A, Trías N, Rodriguez Sande V, Salisbury S, Cuello M, Lens D. Circulating T regulatory cell subsets in patients with untreated lung cancer. Clin Transl Oncol 2022. [PMID: 35445283 DOI: 10.1007/s12094-022-02827-6] [Reference Citation Analysis]
159 Oh J, Carlson JCT, Landeros C, Lee H, Ferguson S, Faquin WC, Clark JR, Pittet MJ, Pai SI, Weissleder R. Rapid Serial Immunoprofiling of the Tumor Immune Microenvironment by Fine Needle Sampling. Clin Cancer Res 2021;27:4781-93. [PMID: 34233961 DOI: 10.1158/1078-0432.CCR-21-1252] [Reference Citation Analysis]
160 Mansuri N, Birkman EM, Heuser VD, Lintunen M, Ålgars A, Sundström J, Ristamäki R, Lehtinen L, Carpén O. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome. Virchows Arch 2021;478:707-17. [PMID: 32954467 DOI: 10.1007/s00428-020-02932-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
161 Sanegre S, Lucantoni F, Burgos-Panadero R, de La Cruz-Merino L, Noguera R, Álvaro Naranjo T. Integrating the Tumor Microenvironment into Cancer Therapy. Cancers (Basel) 2020;12:E1677. [PMID: 32599891 DOI: 10.3390/cancers12061677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
162 Ahmed MM, Gebriel MG, Morad EA, Saber IM, Elwan A, Salah M, Fakhr AE, Shalaby AM, Alabiad MA. Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma. Appl Immunohistochem Mol Morphol 2021;29:401-8. [PMID: 33480605 DOI: 10.1097/PAI.0000000000000903] [Reference Citation Analysis]
163 Han Z, Gong C, Li J, Guo H, Chen X, Jin Y, Gao S, Tai Z. Immunologically modified enzyme-responsive micelles regulate the tumor microenvironment for cancer immunotherapy. Mater Today Bio 2022;13:100170. [PMID: 34938989 DOI: 10.1016/j.mtbio.2021.100170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
164 Lidenge SJ, Tso FY, Mortazavi Y, Ngowi JR, Shea DM, Mwaiselage J, Wood C, West JT. Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi's Sarcoma Patients. Cancers (Basel) 2020;12:E1594. [PMID: 32560243 DOI: 10.3390/cancers12061594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Gudowska-Sawczuk M, Kudelski J, Mroczko B. The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma. Int J Mol Sci 2020;21:E8582. [PMID: 33202536 DOI: 10.3390/ijms21228582] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
166 Deng Q, Li X, Fang C, Li X, Zhang J, Xi Q, Li Y, Zhang R. Cordycepin enhances anti-tumor immunity in colon cancer by inhibiting phagocytosis immune checkpoint CD47 expression. Int Immunopharmacol 2022;107:108695. [PMID: 35305385 DOI: 10.1016/j.intimp.2022.108695] [Reference Citation Analysis]
167 Xu SH, Luo HX, Huang BJ, Yu L, Luo SJ, Hu H, Li Y, Lin XT, Cao ZR, Deng YJ, Zhang SJ. Therapeutic Effect of Catgut Implantation at Acupoint in a Mouse Model of Hepatocellular Carcinoma by Suppressing Immune Escape. Evid Based Complement Alternat Med 2022;2022:5572869. [PMID: 35178106 DOI: 10.1155/2022/5572869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Nirosha Yalamandala B, Chen P, Moorthy T, Huynh TMH, Chiang W, Hu S. Programmed Catalytic Therapy-Mediated ROS Generation and T-Cell Infiltration in Lung Metastasis by a Dual Metal-Organic Framework (MOF) Nanoagent. Pharmaceutics 2022;14:527. [DOI: 10.3390/pharmaceutics14030527] [Reference Citation Analysis]
169 Bradley JH, Barwick S, Horn GQ, Ullrich E, Best B, Arnold JP, Gregg RK. Simulated microgravity-mediated reversion of murine lymphoma immune evasion. Sci Rep 2019;9:14623. [PMID: 31602007 DOI: 10.1038/s41598-019-51106-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
170 Yu H, Fu D, Xu PP, Cheng S, Wang L, Zhang YZ, Zhao WL. Implication of immune cell signature of tumor microenvironment in diffuse large B-cell lymphoma. Hematol Oncol 2021. [PMID: 34331367 DOI: 10.1002/hon.2905] [Reference Citation Analysis]
171 Ferreira PMP, Sousa RWR, Ferreira JRO, Militão GCG, Bezerra DP. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms. Pharmacol Res 2021;168:105582. [PMID: 33775862 DOI: 10.1016/j.phrs.2021.105582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
172 Turbitt WJ, Boi SK, Gibson JT, Orlandella RM, Norian LA. Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice. Cancers (Basel) 2021;13:2295. [PMID: 34064933 DOI: 10.3390/cancers13102295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Dagenborg VJ, Marshall SE, Grzyb K, Fretland ÅA, Lund-Iversen M, Mælandsmo GM, Ree AH, Edwin B, Yaqub S, Flatmark K. Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer. Front Oncol 2021;11:671629. [PMID: 34178659 DOI: 10.3389/fonc.2021.671629] [Reference Citation Analysis]
174 Dosset M, Joseph EL, Rivera Vargas T, Apetoh L. Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors. Cells 2020;9:E1727. [PMID: 32707692 DOI: 10.3390/cells9071727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
175 Zhang Z, Liang Y, Zhong D, Dai Z, Shang J, Lai C, Zou H, Yao Y, Feng T, Huang X. Prognostic value of inflammation‐immunity‐nutrition score in patients with hepatocellular carcinoma treated with anti‐PD‐1 therapy. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24336] [Reference Citation Analysis]
176 Gordin M, Philip H, Zilberberg A, Gidoni M, Margalit R, Clouser C, Adams K, Vigneault F, Cohen IR, Yaari G, Efroni S. Breast cancer is marked by specific, Public T-cell receptor CDR3 regions shared by mice and humans. PLoS Comput Biol 2021;17:e1008486. [PMID: 33465095 DOI: 10.1371/journal.pcbi.1008486] [Reference Citation Analysis]
177 O'Donovan C, Davern M, Donlon NE, Lysaght J, Conroy MJ. Chemokine-targeted therapies: An opportunity to remodel immune profiles in gastro-oesophageal tumours. Cancer Lett 2021;521:224-36. [PMID: 34506844 DOI: 10.1016/j.canlet.2021.09.005] [Reference Citation Analysis]
178 Jiang P, Wang J, Gong C, Yi Q, Zhu M, Hu Z. A Nomogram Model for Predicting Recurrence of Stage I–III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors. JIR 2022;Volume 15:3021-37. [DOI: 10.2147/jir.s362166] [Reference Citation Analysis]
179 Dai D, Xie L, Shui Y, Li J, Wei Q. Identification of Tumor Microenvironment-Related Prognostic Genes in Sarcoma. Front Genet 2021;12:620705. [PMID: 33597971 DOI: 10.3389/fgene.2021.620705] [Reference Citation Analysis]
180 Ma J, Yang Y, Wang L, Jia X, Lu T, Zeng Y, Liu L, Gao Y. Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer. Aging (Albany NY) 2021;13:7211-27. [PMID: 33639614 DOI: 10.18632/aging.202579] [Reference Citation Analysis]
181 Liu C, Chu X, Sun P, Feng X, Huang W, Liu H, Ma Y. Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model. Hum Vaccin Immunother 2018;14:931-40. [PMID: 29271696 DOI: 10.1080/21645515.2017.1420446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
182 Hu Y, Tang C, Zhu W, Ye H, Lin Y, Wang R, Zhou T, Wen S, Yang J, Fang C. Identification of chromosomal instability-associated genes as hepatocellular carcinoma progression-related biomarkers to guide clinical diagnosis, prognosis and therapy. Comput Biol Med 2022;148:105896. [PMID: 35868048 DOI: 10.1016/j.compbiomed.2022.105896] [Reference Citation Analysis]
183 Xie S, Zhang XY, Shan XF, Yau V, Zhang JY, Wang W, Yan YP, Cai ZG. Hyperion Image Analysis Depicts a Preliminary Landscape of Tumor Immune Microenvironment in OSCC with Lymph Node Metastasis. J Immunol Res 2021;2021:9975423. [PMID: 34239944 DOI: 10.1155/2021/9975423] [Reference Citation Analysis]